Alkermes
alkermes molecular design biology rationale commercial opportunity unmet need high value development candidate strong biology rationale capabilities focused within defined scientific platforms targets externally validated and vetted with scientific advisors potential opportunity for first in class or best in class therapies structure activity insight guides molecular design regulatory pathway technical feasibility technical feasibility clinical pathway integrated capabilities in medicinal chemistry protein engineering and molecular modeling utilized to address technical challenges | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
46 of 144
Related slides by other companies
Exscientia
Investor Day
January 2024
ways we can improve probability of success | Exscientia
Moolec Science
Results
December 2023
self owned molecular biology lab | Moolec Science
argenx SE
Investor Day
July 2021
biology rationale is at the core of our indication selection | argenx SE
argenx SE
Investor Day
July 2021
conclusions | argenx SE
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io